• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation

tetano

Editor, Senior Moderator
Nat Commun


. 2021 May 11;12(1):2697.
doi: 10.1038/s41467-021-23036-9.
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation


Sisi Kang[SUP] #[/SUP][SUP] 1 [/SUP], Mei Yang[SUP] #[/SUP][SUP] 1 [/SUP], Suhua He[SUP] #[/SUP][SUP] 1 [/SUP], Yueming Wang[SUP] #[/SUP][SUP] 2 3 [/SUP], Xiaoxue Chen[SUP] 1 [/SUP], Yao-Qing Chen[SUP] 4 [/SUP], Zhongsi Hong[SUP] 5 [/SUP], Jing Liu[SUP] 6 [/SUP], Guanmin Jiang[SUP] 7 [/SUP], Qiuyue Chen[SUP] 1 [/SUP], Ziliang Zhou[SUP] 1 [/SUP], Zhechong Zhou[SUP] 1 [/SUP], Zhaoxia Huang[SUP] 1 [/SUP], Xi Huang[SUP] 8 [/SUP], Huanhuan He[SUP] 1 [/SUP], Weihong Zheng[SUP] 2 3 [/SUP], Hua-Xin Liao[SUP] 9 10 [/SUP], Fei Xiao[SUP] 11 12 [/SUP], Hong Shan[SUP] 13 14 [/SUP], Shoudeng Chen[SUP] 15 [/SUP]



Affiliations

Abstract

Although human antibodies elicited by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein are profoundly boosted upon infection, little is known about the function of N-reactive antibodies. Herein, we isolate and profile a panel of 32 N protein-specific monoclonal antibodies (mAbs) from a quick recovery coronavirus disease-19 (COVID-19) convalescent patient who has dominant antibody responses to the SARS-CoV-2 N protein rather than to the SARS-CoV-2 spike (S) protein. The complex structure of the N protein RNA binding domain with the highest binding affinity mAb (nCoV396) reveals changes in the epitopes and antigen's allosteric regulation. Functionally, a virus-free complement hyperactivation analysis demonstrates that nCoV396 specifically compromises the N protein-induced complement hyperactivation, which is a risk factor for the morbidity and mortality of COVID-19 patients, thus laying the foundation for the identification of functional anti-N protein mAbs.
 
Back
Top Bottom